| A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy (NCT03338062) | Indiana University | 2017-06-13 |
| Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis (NCT03009461) | Peking University | 2017-06-01 |
| Clinical Significance of Hepatic and Circulating microRNAs miR-221 and miR-222 in Hepatocellular Carcinoma (NCT02928627) | University of Aberdeen | 2017-06-01 |
| Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC) (NCT03084380) | Xinqiao Hospital of Chongqing | 2017-06-01 |
| Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma (NCT03129685) | The National Ribat University | 2017-05-20 |
| Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma (NCT03114085) | First Affiliated Hospital of Guangxi Medical University | 2017-05-20 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
| Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) (NCT03162198) | Institute of Liver and Biliary Sciences, India | 2017-05-15 |
| Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation (NCT06018857) | Federico Aucejo | 2017-05-11 |
| A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT) (NCT03086564) | Yuehua Huang | 2017-05-01 |
| Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC (NCT03175705) | Beijing YouAn Hospital | 2017-05-01 |
| Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients (NCT02988440) | Novartis Pharmaceuticals | 2017-04-20 |
| Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry (NCT03233360) | National Cancer Centre, Singapore | 2017-04-17 |
| Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (NCT03035006) | Taiwan Liposome Company | 2017-04-14 |
| Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma (NCT03110068) | Ming Kuang | 2017-04-10 |
| Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC (NCT03175679) | Beijing YouAn Hospital | 2017-04-01 |
| Radiomics of Hepatocellular Carcinoma (NCT02757846) | Chinese Academy of Sciences | 2017-04-01 |
| Pembrolizumab Plus Y90 Radioembolization in HCC Subjects (NCT03099564) | Ashwin Somasundaram | 2017-03-28 |
| Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma (NCT02989870) | H. Lee Moffitt Cancer Center and Research Institute | 2017-03-27 |
| Biologic Basis of Liver Cancer From Chronic Hepatitis B (NCT03300414) | University of California, Davis | 2017-03-20 |
| CAR-GPC3 T Cells in Patients With Refractory Hepatocellular Carcinoma (NCT03146234) | RenJi Hospital | 2017-03-17 |
| Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma (NCT03066557) | Jiangsu Cancer Institute & Hospital | 2017-03-15 |
| Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor (NCT03093688) | Shanghai Public Health Clinical Center | 2017-03-01 |
| Central Obesity and Hepatocellular Carcinoma (NCT03082378) | Chinese PLA General Hospital | 2017-03-01 |
| Comparison of SBRTand Repeat TACE for HCC (NCT03326375) | Gangneung Asan Hospital | 2017-03-01 |
| Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease (NCT03307408) | Centre Hospitalier Universitaire de Nice | 2017-02-28 |
| Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib. (NCT03140332) | Centre Hospitalier Universitaire, Amiens | 2017-02-27 |
| Observational Study on Patients With Hepatobiliary Tumors (NCT04637048) | Gang Chen, MD | 2017-02-16 |
| A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma (NCT03006926) | Eisai Co., Ltd. | 2017-02-13 |
| Clemizole HCl for Subjects With Hepatocellular Carcinoma (NCT03069508) | Eiger Group International, Inc. | 2017-02-13 |
| Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis (NCT01710293) | VA Office of Research and Development | 2017-01-27 |
| Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies (NCT02950025) | Washington University School of Medicine | 2017-01-19 |
| Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection (NCT03575806) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2017-01-09 |
| Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response (NCT03254121) | Karolinska Institutet | 2017-01-01 |
| Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus (NCT02971345) | Shanghai Zhongshan Hospital | 2017-01-01 |
| Combined Therapy for Hepatocellular Carcinoma >3-<5 cm (NCT04721470) | Zagazig University | 2017-01-01 |
| Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma (NCT05017922) | Qilu Hospital of Shandong University | 2017-01-01 |
| Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC) (NCT03208335) | Chinese PLA General Hospital | 2017-01-01 |
| Immunological Response After Ablative Therapy in the Liver (NCT03040453) | Karolinska Institutet | 2017-01-01 |
| The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma (NCT03793322) | Zhujiang Hospital | 2017-01-01 |
| A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC (NCT03116984) | Shanghai Zhongshan Hospital | 2017-01-01 |
| Yang Yin Fu Zheng Jie Du Therapy in Recurrence of Hepatocellular Carcinoma Less Than 3 cm in Diameter (NCT04264962) | Beijing Ditan Hospital | 2017-01-01 |
| Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma (NCT02834780) | H3 Biomedicine Inc. | 2016-12-28 |
| Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery (NCT02881554) | University of Washington | 2016-12-21 |
| Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma (NCT03033446) | National Cancer Centre, Singapore | 2016-12-20 |
| MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison (NCT04652947) | University Hospital, Angers | 2016-12-07 |
| Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC) (NCT03046979) | Tianjin Medical University Cancer Institute and Hospital | 2016-12-01 |
| Laparoscopic Surgery VS RFA for Recurrent HCC (NCT02785380) | Sun Yat-sen University | 2016-12-01 |
| Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis (NCT02973516) | Guerbet | 2016-12-01 |
| A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma (NCT02854839) | GC Cell Corporation | 2016-11-28 |
| LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry) (NCT03053596) | Terumo Europe N.V. | 2016-11-01 |
| Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening (NCT02833298) | Icahn School of Medicine at Mount Sinai | 2016-11-01 |
| Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil (NCT02987699) | Sun Yat-sen University | 2016-11-01 |
| DAA in the Risk of Recurrence After Curative Treatment of HCC (NCT02959359) | Taipei Veterans General Hospital, Taiwan | 2016-11-01 |
| Trial of TRC105 and Sorafenib in Patients With HCC (NCT02560779) | Tracon Pharmaceuticals Inc. | 2016-11-01 |
| A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC (NCT03295006) | Boston Scientific Corporation | 2016-10-31 |
| Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer (NCT02942329) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2016-10-01 |
| Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma (NCT02946138) | Shanghai Proton and Heavy Ion Center | 2016-10-01 |
| HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B. (NCT02973685) | Sun Yat-sen University | 2016-10-01 |
| Emulsion Versus Suspension in Chemoembolization for Hepatocellular Carcinoma (NCT03268499) | Chinese University of Hong Kong | 2016-09-09 |
| HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China (NCT02743065) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2016-09-01 |
| A Study of Anlotinib in Patients With Hepatocellular Carcinoma (NCT02809534) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2016-09-01 |
| Chronic Hepatitis B Virus Infection in Zambia (NCT03158818) | University of Alabama at Birmingham | 2016-08-23 |
| A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver Cancer (NCT02828124) | Bristol-Myers Squibb | 2016-08-23 |
| Impact of Y90 Radiation Segmentectomy on HCC (NCT03248375) | Icahn School of Medicine at Mount Sinai | 2016-08-03 |
| Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma (NCT02927626) | Beijing Ditan Hospital | 2016-08-01 |
| The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial. (NCT02987907) | Sun Yat-sen University | 2016-08-01 |
| HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC (NCT02856126) | Sun Yat-sen University | 2016-08-01 |
| The Combination Effect of Statin Plus Metformin on Relapse-free (NCT02819869) | Taipei Medical University WanFang Hospital | 2016-08-01 |
| Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment (NCT03042520) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2016-08-01 |
| MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma (NCT02575339) | Kathy Miller | 2016-07-18 |
| A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) (NCT02821754) | National Cancer Institute (NCI) | 2016-07-05 |
| the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma (NCT03777475) | Sun Yat-sen University | 2016-07-01 |
| Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma (NCT04414956) | Korea University | 2016-07-01 |
| Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance (NCT02854241) | Seoul National University Hospital | 2016-07-01 |
| A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors (NCT02886897) | Sun Yat-sen University | 2016-07-01 |
| SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC (NCT03578874) | The University of Hong Kong | 2016-06-20 |
| Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy (NCT02432963) | City of Hope Medical Center | 2016-06-14 |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection (NCT02772003) | National Cancer Institute (NCI) | 2016-06-06 |
| Prospective, Multicenter HCCIS Evaluation Study (NCT02718235) | University of Regensburg | 2016-06-01 |
| Randomized Phase II Trial of Chemoembolization and Sorafenib (NCT02908165) | Yale University | 2016-06-01 |
| Novel Gallium Imaging in Hepatocellular Carcinoma (NCT03116945) | Rutgers, The State University of New Jersey | 2016-06-01 |
| Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence (NCT03197155) | Hospices Civils de Lyon | 2016-06-01 |
| Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC (NCT04722120) | Seoul National University Hospital | 2016-06-01 |
| Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection (NCT02867280) | Sun Yat-sen University | 2016-06-01 |
| Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224) (NCT02702414) | Merck Sharp & Dohme LLC | 2016-05-31 |
| Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240) (NCT02702401) | Merck Sharp & Dohme LLC | 2016-05-26 |
| Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma (NCT03267641) | National Cancer Centre, Singapore | 2016-05-16 |
| Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma (NCT02658019) | Lynn Feun, MD | 2016-05-06 |
| Surefire Precision Infusion System Registry (NCT02967523) | Surefire Medical, Inc. | 2016-05-01 |
| Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC (NCT02774187) | Sun Yat-sen University | 2016-05-01 |
| Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC (NCT03047603) | Eastern Hepatobiliary Surgery Hospital | 2016-05-01 |
| A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure (NCT02772029) | The First Affiliated Hospital of Zhengzhou University | 2016-05-01 |
| The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study (NCT05121571) | Sun Yat-sen University | 2016-04-21 |
| Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer (NCT02595866) | National Cancer Institute (NCI) | 2016-04-04 |
| Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC) (NCT03156582) | University Hospital, Grenoble | 2016-04-01 |
| LifePearl-Doxo Pharmacokinetic (PK) Study (NCT02548780) | Terumo Europe N.V. | 2016-04-01 |
| Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients (NCT02523053) | Eastern Hepatobiliary Surgery Hospital | 2016-04-01 |
| Contrast-enhanced Ultrasound Evaluation of Chemoembolization (NCT02764801) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2016-04-01 |
| LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma (NCT02524119) | University of Texas Southwestern Medical Center | 2016-04-01 |